Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion"

Affiliations

Comment

Shelagh B Coutts et al. Stroke. 2015 Jun.

. 2015 Jun;46(6):e150.

doi: 10.1161/STROKEAHA.115.009240. Epub 2015 Apr 21.

¹ Departments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.

No abstract available

Comment on

Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB, Dubuc V, Mandzia J, Kenney C, Demchuk AM, Smith EE, Subramaniam S, Goyal M, Patil S, Menon BK, Barber PA, Dowlatshahi D, Field T, Asdaghi N, Camden MC, Hill MD; TEMPO-1 Investigators. Coutts SB, et al. Stroke. 2015 Mar;46(3):769-74. doi: 10.1161/STROKEAHA.114.008504. Epub 2015 Feb 12. Stroke. 2015. PMID: 25677596 Clinical Trial.
Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
Behrouz R, Mutgi SA, Silver B. Behrouz R, et al. Stroke. 2015 Jun;46(6):e149. doi: 10.1161/STROKEAHA.115.009193. Epub 2015 Apr 21. Stroke. 2015. PMID: 25899241 No abstract available.